CDC Reports Fourth Death Blamed on Contaminated Eye Drops

Eye drops are supposed to be the “calm down, buddy” friend for your eyeballs. So when the CDC reports that a
fourth death is linked to contaminated artificial tears, it lands with the emotional energy of a
fire alarm going off in a library. Quiet product. Loud consequences.

This story isn’t just about one bad bottle. It’s about how a sterile product can become a delivery system for a rare,
hard-to-treat bacteriumand what that means for anyone who’s ever grabbed over-the-counter eye drops because screens, allergies,
contacts, or life made their eyes feel like sandpaper.

What the CDC Update Actually Says (and Why It Matters)

The CDC’s investigation focused on an outbreak of extensively drug-resistant Pseudomonas aeruginosa associated with
certain artificial tears. In its May 2023 update, the CDC reported 81 patients across 18 states.
Among people with clinical infections (not just screening tests), public health officials documented severe outcomes:
vision loss, enucleation (surgical removal of an eyeball), and four deaths.

If you’re thinking, “Waithow do eye drops end up connected to deaths?” you’re not alone. The short version: the outbreak strain
wasn’t your everyday germ. It was a rare, highly resistant organism that can cause serious infectionespecially in people who are
medically fragile or already in healthcare settings.

Quick Timeline of the Contaminated Eye Drops Outbreak

Outbreak investigations can feel like detective work with lab coats. Here’s the simplified timeline that explains the headline:

• May 2022–Jan 2023: Specimens later tied to the outbreak were collected across multiple states.
• Feb 1, 2023: CDC issues a national alert to clinicians about a rare, extensively drug-resistant strain.
• Early Feb 2023: FDA warns consumers not to use certain artificial tears; recalls follow.
• March 2023: Public updates describe expanding case counts and serious eye outcomes.
• Mid-May 2023: CDC reports 81 patients and updates the severe-outcome totals, including the fourth death.

That “fourth death” isn’t a random number. It’s a signal that the outbreak wasn’t limited to mild irritation or routine conjunctivitis.
This was a high-stakes contamination event involving a pathogen that laughs in the face of many common antibiotics.

Meet the Culprit: A Rare, Highly Drug-Resistant Pseudomonas

Pseudomonas aeruginosa is a bacterium found widely in the environment (think: soil and water). In healthy people,
it’s not usually a daily threat. But in hospitals and long-term care facilitiesespecially among people with weakened defensesit can
cause serious infections in the eyes, lungs, urinary tract, or blood.

Why antibiotic resistance made this outbreak so scary

The outbreak strain identified by CDC had a resistance profile that limited routine treatment options. In plain English: even if clinicians
did everything rightculture, diagnose, treatthere were fewer reliable medications to reach for. Some reports noted that newer agents
(like cefiderocol) showed activity against a subset of tested isolates, but this is not the kind of situation anyone
wants to “wing it” with.

CDC also described how specialized optionslike advanced susceptibility testing and even investigational approaches such as
bacteriophage activity testingwere part of the broader clinical conversation. Translation: this outbreak pushed into
“call the specialists” territory fast.

How Can Eye Drops Cause Bloodstream Infections (Seriously)?

It sounds like a plot hole, but anatomy is extremely committed to being interconnected. Your eyes drain into your nose through
tear ducts. That connection is one reason eye infections can spread or become complicatedespecially if the infecting
organism is aggressive and the person has other vulnerabilities.

In this outbreak, infections weren’t only found in eye-related specimens. Investigators identified outbreak-related bacteria from multiple
body sites (including respiratory specimens and blood), which helped explain why outcomes could be severe.

Which Eye Drops Were Involvedand What Was Recalled?

The CDC and FDA focused their recommendations on a small set of products that shared manufacturing connections and were repeatedly identified
in patient histories.

EzriCare Artificial Tears

EzriCare Artificial Tears came up again and again in exposure histories and facility clusters. A key concern was that it was
preservative-free yet packaged in a multidose bottlea combination that can be safe when engineering and
sterility controls are excellent, but risky if contamination occurs because there’s no preservative “backup plan.”

Delsam Pharma Artificial Tears and Artificial Ointment

CDC and FDA communications also advised people to stop using Delsam Pharma’s Artificial Tears and
Delsam Pharma’s Artificial Ointment, which were tied to the same manufacturing source and recall actions.

Importantly, the public health messaging didn’t imply that every eye drop on Earth was suddenly suspect. The focus was: stop using
the recalled products, watch for symptoms, and report potential cases so investigators could map the true scope.

Warning Signs: Symptoms That Shouldn’t Be “Wait and See”

Lots of eye issues are annoying but not dangerous. This outbreak was different because the infections could be severe and fast-moving.
If someone used the recalled products, the CDC advised seeking medical care promptly for signs of an eye infection.
Symptoms commonly listed by public health authorities included:

• Yellow, green, or clear discharge from the eye
• Eye pain or significant discomfort
• Redness of the eye or eyelid
• A “something is in my eye” foreign body sensation
• Light sensitivity
• Blurry vision or sudden vision changes

And here’s the non-funny part: if vision changes are rapid, pain is intense, or the person is immunocompromised, older, or in a care
facility, this is not the moment for “let’s see if it’s better tomorrow.”

What to Do If You Used the Recalled Drops

No panic-buying goggles required. But a calm, practical checklist helps.

For consumers

• Stop using the recalled products immediately and discard them (even if the bottle looks fine).
• If you have symptoms, seek medical care and mention the specific product you used.
• Don’t share eye drops (even within a household). This is not a “communal ketchup” situation.
• Report adverse events to FDA’s safety reporting system if you suspect an issue.

For caregivers, clinics, and long-term care facilities

• Remove recalled products from supply areas and medication carts.
• Monitor residents/patients who used the products for early symptoms.
• When infection is suspected, clinicians may perform cultures and request susceptibility testing, especially for severe keratitis.
• Follow infection control guidance for drug-resistant organisms when indicated.

The Bigger Lesson: Sterility Isn’t Optional for Eye Products

Eye products are supposed to be sterile because they bypass a lot of your body’s usual defenses. When sterility fails, the risk isn’t just
“mild irritation.” It can be corneal infection, scarring, procedures, permanent vision lossand, in rare but real situations, systemic infection.

This outbreak also highlighted a broader theme that regulators and clinicians have been talking about for years: the combination of
global manufacturing, high-volume OTC products, and sterile drug standards demands strict oversight.
FDA inspection findings and subsequent compliance actions underscored how manufacturing and quality systems matternot as paperwork, but as prevention.

Preservative-free isn’t the villain; packaging is the plot twist

Many people prefer preservative-free drops because preservatives can bother sensitive eyes, especially with frequent use.
But preservative-free products typically rely on smart packaginglike single-use vials or specialized bottle designsto reduce contamination risk.
When a preservative-free product is in a multidose bottle, sterility controls have to be exceptionally strong. If contamination occurs, bacteria can
multiply more easily because nothing in the formula is designed to stop them.

FAQ: The Questions People Actually Ask

Were all eye drops recalled?

No. The outbreak investigation and recall actions focused on specific products and manufacturers. There were also other eye product recalls in 2023
for sterility concerns, but not every recall was linked to this particular outbreak strain.

If I used artificial tears in 2023, should I be worried?

If you didn’t use the recalled products and you don’t have symptoms, this is usually a “stay informed” situation, not a “lose sleep” situation.
If you did use a recalled product, follow the checklist above and seek care if symptoms appear.

What should I buy instead?

Your clinician or pharmacist can recommend alternatives based on why you use drops (dry eye, allergies, contacts, post-surgery). As a general
consumer strategy, stick to reputable retailers, avoid using expired products, don’t touch the bottle tip to your eye or fingers, and consider
single-use vials if you need preservative-free drops frequently.

Final Takeaways

The CDC’s report of a fourth death tied to contaminated eye drops is a reminder that “over-the-counter” does not mean “low-risk.”
Sterile products have to be sterile every time. When they aren’t, the consequences can range from painful infections to permanent vision lossand, in
rare cases, death.

The good news is that public health surveillance worked: clusters were recognized, a strain was identified, recalls were issued, and consumers were
warned. The best next step is the boring one that saves eyes: check your products, follow recall guidance, and take symptoms seriously.

Real-World Experiences: What People Went Through (and What They Learned)

Outbreak numbers are important, but they can feel abstract until you picture how this plays out in real life. Many of the “experiences” around
contaminated eye drops fall into a few repeating patternsoften messy, confusing, and emotionally exhausting, because eye problems mess with one of the
senses people rely on constantly.

Experience #1: “It was just dryness… until it wasn’t.” A common story started with normal dry-eye frustration: burning, gritty
sensation, and that end-of-day screen fatigue. Artificial tears were part of a daily routinekept in a purse, desk drawer, or bedside table. When
symptoms escalated, people described a sudden shift from mild irritation to “my eye is angry” territory: significant redness, pain, and discharge.
The surprise was how quickly it changed. Several clinicians have described that severe keratitis doesn’t politely wait for a convenient appointment.
People who sought care early often emphasized the same lesson afterward: don’t normalize new pain or worsening vision.

Experience #2: The recall confusion spiral. Recalls sound straightforward on paperuntil you’re staring at a bottle with tiny print
and wondering if your brand name matches what you saw in a headline. Some people tossed everything “just in case.” Others hesitated because the drops
were working and alternatives felt expensive or hard to find. Pharmacies and clinics reported spending real time helping customers decode labels and
switch products safely. A practical takeaway many shared: keep the box (at least until you know the product is fine) and take a quick photo of the
label so you can compare later if a recall notice pops up.

Experience #3: Care facilities and the “shared supply” trap. In long-term care settings, supplies are often standardized to reduce
medication errors and simplify stocking. But outbreaks teach a painful lesson: when a product is widely distributed, it can show up in many places at
once. Staff described having to inventory carts, storage rooms, and resident suppliesthen notify families and clinicians, monitor residents for
symptoms, and coordinate cultures when infection was suspected. The lesson here wasn’t just “remove the product.” It was “build systems that make
removal fast,” like tracking lot numbers, documenting where products are used, and having a rapid replacement plan.

Experience #4: The emotional toll of eye infections. People dealing with serious eye infections often describe fear more than pain:
fear of losing vision, fear of surgery, fear that treatment won’t work. For families, it can look like a sudden medical crisis triggered by something
that seemed harmless. In outbreaks involving drug-resistant bacteria, that anxiety is amplifiedbecause the words “limited treatment options” hit hard
when the body part involved is your eye. Many patients and caregivers later said they wished they’d known earlier that “eye discharge + pain + blurry
vision” isn’t a DIY situation.

Experience #5: Small hygiene habits that suddenly feel very big. After the headlines, lots of people re-learned eye-drop basics:
don’t touch the tip to your eye, don’t set the cap down on questionable surfaces, don’t share drops, wash hands first, and don’t use a bottle that
looks damaged or contaminated. These tips can sound like nagginguntil you understand that contamination doesn’t need a dramatic event. Sometimes it’s
just one accidental touch, and then bacteria get a free ride.

The unifying theme across these experiences is simple: people didn’t do something reckless. They used a common product the way millions do.
That’s why this story matters. It’s less about blaming consumers and more about demanding that sterile products stay sterilebecause the “little”
items in the medicine cabinet can carry very big consequences.